PCB copy board upgrade promotes the development of medical device industry

PCB copy board upgrade promotes the development of medical device industry

At present, "difficult to see a doctor, expensive to see a doctor" has become the focus and hot issue of the whole society. The reason why China has this deadly "short board" is because China is a populous country and the aging is accelerating. It is also because China's middle and high-end medical device market is mainly dominated by multinational companies. For a long time, China's medical device research institutions, high-end talents and compound talents are lacking, and the homogenization competition is serious, resulting in the lag of new product development, slow product updates, and it is difficult for China's medical device products to reach foreign standards. Domestic enterprises must tide over the difficulties, but also need to review the situation, capture opportunities, reverse research on PCB copy board, and innovate at a high starting point, or help medical institutions to seek development in the game of opportunities and challenges.

Looking for "short board"

In recent years, imported medical devices have entered the medical field and the ordinary people's homes at an increasing speed. Due to their high-end, advanced and irreplaceable, they have gradually become a symbol of the public's self-healing and even the medical level of medical institutions. What is not appropriate is that the relevant inspection work and maintenance technology failed to follow up. Apart from the influence of some external factors, the most important reason is that the monitor does not know anything about the technical principle of medical devices.

In view of the problems of mechanical failure, large sampling error and inaccurate monitoring data when using medical equipment in China, the technical support function of PCB copy board is even more essential. PCB copy board technology can not only analyze the original product PCB file, schematic diagram, BOM list and other complete technical materials, but also play the role of leak detection and maintenance monitoring for domestic instruments, and can also digest and absorb PCBs for high-end medical equipment abroad. Reformed the board for secondary development. Therefore, China's medical devices also need to have a mature process, and copy board technology is a good helper to avoid risks.

Word "upgrade"

Although there are many "short boards" in China's medical equipment, PCB copy board can not only check for missing, but also the space for secondary upgrade. Among high-end imported medical devices, PCB copy board upgrades have more development advantages. This is because the latter introduces digestion, absorption and innovation, with small investment, short development cycle, weak patent restrictions, small environmental pollution, and can quickly promote the growth of China's medical device industry.

European And American Market

Europe: 2011 was a strong year for European plant extracts. As the largest herbal medicine market in the world, products made from plant extracts are favored by local consumers. From January to December, China's export of plant extracts to EU was 290 million US dollars, up 63.2% year on year, the export quantity was 11,000 tons, up 15.1% year on year, the average export price increased 41.8% year on year, showing a good situation of both volume and price rising. The main exporters of plant extracts to Europe are Spain, Germany, France and the United Kingdom.

American market: The North American market or American market is the most important export market of Chinese plant extracts, ranking first in plant extracts export since 2005. Taking dietary supplements has become a habit for most Americans, which has led to a growing demand for plant extracts in the world's largest market for dietary supplements. The US market has become a global vane for medicinal and health plant extracts, and the increase and decrease of market demand will directly affect the changes of other global markets. In 2011, China exported $180 million of plant extracts to the United States, up 54% year on year. The export volume is 8,050 tons, up 32% year on year.

European, American,USP,EP

Shaanxi Kepler Biotech Co.,Ltd , https://www.keplerherb.com